1-4 of 4
ixmyelocel-t
Close
Sort by
Journal Articles

Regional Perfusion in Sickle Cell Subjects and Normal Controls Is a Physiological Biomarker of Mental Stress and Fear of Pain

Maha Khaleel, MD, Payal Shah, MS, Wanwara Thuptimdang, MS, John Sunwoo, MS, Patjanaporn Chalacheva, PhD, Roberta Miyeko Kato, MD, Jon A Detterich, MD, John C Wood, MD PhD, Jennie Tsao, PhD, Lonnie Zeltzer, MD, Richard Sposto, PhD, Michael C.K. Khoo, PhD, Thomas D. Coates, MD
Journal: Blood
Blood (2016) 128 (22): 2492.
https://doi.org/10.1182/blood.V128.22.2492.2492
Published: 2016
Journal Articles

A Phase III, Randomized, Double-Blind Trial to Evaluate Efficacy and Safety of Isavuconazole Versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Hematopoietic Stem Cell Transplant Patients with Invasive Aspergillosis

Werner J Heinz, MD, Oliver A Cornely, MD, Billy Franks, PhD, Fei Shi, PhD, Nkechi Azie, MD, Johan Maertens, MD
Journal: Blood
Blood (2014) 124 (21): 1133.
https://doi.org/10.1182/blood.V124.21.1133.1133
Published: 2014
Journal Articles

Strategies To Identify Effective Treatments For Proteasome Inhibitor Resistant Multiple Myeloma

Brian Van Ness, Ph.D, Holly A. F. Stessman, Ph.D., Linda B. Baughn, Ph.D., Aatif Mansoor, Amit Mitra, Nathan G. Dolloff, PhD, Chad L. Myers, PhD, Fenghuang Zhan, MD&PhD, Taylor Harding, B.S.
Journal: Blood
Blood (2013) 122 (21): 278.
https://doi.org/10.1182/blood.V122.21.278.278
Published: 2013
Journal Articles

Primary Prophylaxis against Invasive Fungal Infections (IFI) with Posaconazole (POS) or Voriconazole (VRC) Shows Better Efficacy Compared to No Systemic Prophylaxis during Induction and Consolidation Chemotherapy Cycles of Adult Acute Leukemia Patients

Mario E Ojeda Uribe, MD, Catherine Berg, Alain Gravet, Eric Sauleau, Dominique Bourderont, Celine Haby
Journal: Blood
Blood (2008) 112 (11): 4834.
https://doi.org/10.1182/blood.V112.11.4834.4834
Published: 2008